Pemazyre

Ended Awarded

Contract number
36C25221F0034
Awardee
Awarding agency
Obligated
$12,725

Award facts

Contract value 100% obligated
$12,725.23 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Carrollton, TX 75010, USA

Award details come from SAM.gov/FPDS.

About this award

Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The delivery order, which has no set aside designation and completion date of October 30, 2020, is for the provision of PEMAZYRE to treat patients. The firm fixed price order was awarded on October 5, 2020 under Incyte's master GSA Schedule contract vehicle. The place of performance is Carrollton, Texas where the VA network will receive the requested pharmaceutical supplies.

Quick answers

Who was awarded contract 36C25221F0034?

36C25221F0034 was awarded to Incyte Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on October 5, 2020.

How much is contract 36C25221F0034 worth?

The government has obligated $12,725 on 36C25221F0034.

Is contract 36C25221F0034 an order under another contract?

Yes. 36C25221F0034 is a delivery order under 36F79720D0189, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25221F0034 competed?

The extent of competition for 36C25221F0034 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award